+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ciprofibrate"

Ciprofibrate Market - Global Forecast 2025-2032 - Product Thumbnail Image

Ciprofibrate Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 180 Pages
  • Global
From
Fibrate Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Fibrate Drugs Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 181 Pages
  • Global
From
Etofibrate Market - Global Forecast 2025-2032 - Product Thumbnail Image

Etofibrate Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 182 Pages
  • Global
From
Hyperlipidemia Drugs Market Report 2025 - Product Thumbnail Image

Hyperlipidemia Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Ciprofibrate is a cardiovascular drug used to treat high cholesterol and triglyceride levels. It is a fibrate, a type of lipid-lowering medication that works by increasing the breakdown of fats in the body. Ciprofibrate is used to reduce the risk of heart attack, stroke, and other cardiovascular diseases. It is also used to reduce the risk of pancreatitis in people with high triglyceride levels. Ciprofibrate is available in tablet form and is usually taken once or twice daily. Ciprofibrate is a widely used drug in the cardiovascular market. It is used to treat a variety of conditions, including high cholesterol and triglyceride levels, and to reduce the risk of heart attack, stroke, and other cardiovascular diseases. It is also used to reduce the risk of pancreatitis in people with high triglyceride levels. Some companies in the Ciprofibrate market include Pfizer, Merck, Sanofi, and Novartis. Show Less Read more